Monday, February 28, 2022: Life Sciences

Two small biotech companies sued Moderna Inc. on claims that it infringed on their patent rights for a technology they said was key to Moderna developing its mRNA vaccine for COVID-19. Moderna has said it expects vaccine sales to top $19 billion in 2022.The two...

Monday, February 28, 2022: Life Sciences

Drugmaker Viatris Inc., formerly known as Mylan NV, will pay $264 million to settle a class-action lawsuit alleging it engaged in anticompetitive behavior to delay generic competition to its EpiPen allergy treatment. The litigation has been ongoing for years,...